Surgery Clinical Trial
Official title:
Comparsion of the Effect of High Versus Low Mean Arterial Pressure (MAP) Levels on Clinical Outcomes in Elderly Patients During Noncardiothoracic Surgery Under General Anesthesia
This will be a multicentre, randomised, controlled and prospective clinical trial. All participants provided their written informed consent to participate in a randomized trial that examined the effects of low-level MAP (60-70 mmHg) vs. high-level MAP (90-100 mmHg) in elderly patients (65 or more years of age) during noncardiothoracic surgery under general anesthesia. The investigators hypothesise high-level blood presure of the intervention for reducing the incidence of post-operative complications.
This will be a multicentre, randomised, controlled and prospective clinical trial. Elderly
patients will be included from seven centers, including Shenzhen People's Hospital
affiliated to Jinan University, West China Hospital affiliated to Sichuan University, Taihe
Hospital affiliated to Hubei University of Medicine, The Third Affiliated Hospital of
Kunming Medical University, Sichuan Provincial People's Hospital, Guizhou Provincial
People's Hospital and Henan Provincial People's Hospital. This research protocol was
approved by the Institutional Review Board of Jinan University (2016001).
On the day of surgery, patients come to the operating room and are provided with standard
monitoring. General anesthesia is given using midazolam and propofol, opioids, muscle
relaxants and maintained with sevoflurane with inhaled concentrations of 1.5% sevoflurane in
oxygen. Supplemental dosing of 1 μg/kg of fentanyl is used every hour from induction up to
approximately 1 hour prior to the end of surgery. A tramadol bolus of 2 mg/kg is given 15 to
30 mins before the end of surgery. Propofol infusion is stopped 5 to 10 mins prior to the
end of surgery, whereas at the end of skin closure, remifentanil was discontinued.
According to grouping, MAP is regulated to the goal level (60-70 mmHg or 95-100 mmHg) during
general anesthesia. If necessary, intravenous antihypertensives (urapidil or phenylephrine
when mean arterial pressure exceeded 10 mmHg of the target value), rather than more
anesthesia, may be used in situations wherein sympathetic stimulation was high; yet a
sufficient amount of anesthesia was being administered and bispectral index showed an
adequate depth of hypnosis. Sedation was provided by a propofol infusion targeted to a BIS
number of approximately 50 during general anesthesia. Atropine and esmolol would be used at
the time of heart rate <50 beats/min and >110 beats/min, respectively.
Lactated Ringer's solution was given to bring the maintenance fluids to 10 ml/kg/h. Blood
loss could be corrected for in a 1:1 ratio using gelofusine. Hospital transfusion guidelines
were used to determine whether blood products were necessary (haemoglobin level less than 10
g/dl in patients with cardiac comorbidities, and below 7 g.dl-1 in those without cardiac
disease). For later starting cases, an additional bolus of Ringer's solution of 1.5
ml/kg/fasted hour from 8 AM was given to bring the total 2 ml/kg/fasted hour. If urine
output decreased to <0.5 mL/kg/h for 1 hour, fursemide 0.3 mg/kg was given.
Mechanical ventilation patterns are adjusted to obtain an end-tidal carbon dioxide value of
35-45 mmHg, at 5-10 min after induction of anesthesia.
For patients with endotracheal tubes, intravenous sedatives including propofol or midazolam
were administrated continuously and titrated by bedside nurses to a target sedation level.
Daily awakening is used for those who were not extubated in the morning.
All patients receive patient controlled intravenous analgesia during postoperative days 1 to
3.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT03213314 -
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
|
N/A | |
Enrolling by invitation |
NCT05534490 -
Surgery and Functionality in Older Adults
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
Recruiting |
NCT06397287 -
PROM Project Urology
|
||
Recruiting |
NCT04444544 -
Quality of Life and High-Risk Abdominal Cancer Surgery
|
||
Completed |
NCT04204785 -
Noise in the OR at Induction: Patient and Anesthesiologists Perceptions
|
N/A | |
Completed |
NCT03432429 -
Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
|
||
Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Not yet recruiting |
NCT05467319 -
Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
|
Phase 3 | |
Recruiting |
NCT04602429 -
Children's Acute Surgical Abdomen Programme
|
||
Completed |
NCT03124901 -
Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor
|
N/A | |
Completed |
NCT04595695 -
The Effect of Clear Masks in Improving Patient Relationships
|
N/A | |
Recruiting |
NCT06103136 -
Maestro 1.0 Post-Market Registry
|
||
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04059328 -
Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
|
||
Recruiting |
NCT03697278 -
Monitoring Postoperative Patient-controlled Analgesia (PCA)
|
N/A |